Statistical Analysis of Patient-Specific Pathway Activities via Mixed Models

Area of Science:

• Genomics
• Systems Biology
• Biostatistics

Background:

• Complex diseases exhibit heterogeneity, with different molecular pathways causing similar phenotypes.
• Identifying patient-specific pathway dysregulation is essential for personalized treatment regimes.
• Current methods often focus on group-level pathway analysis, overlooking individual variations.

Purpose of the Study:

• To develop and validate a statistical framework for analyzing patient-specific pathway activities.
• To assess the dysregulation of specific pathways in individual patients compared to controls.
• To apply the methodology to a Type 2 Diabetes dataset to understand pathway involvement in individual patients.

Main Methods:

• Utilized a mixed models framework for statistical analysis of patient-specific pathway activities.
• Compared individual pathway gene expression profiles against a control group's established norm.
• Validated the hypothesis testing procedure using a gene expression dataset with realistic correlation patterns.

Main Results:

• The proposed hypothesis testing procedure demonstrated an accurate false positive rate (Type I error).
• Analysis of a Type 2 Diabetes dataset revealed a known diabetes-associated pathway was dysregulated in less than 30% of patients.
• This finding explains moderate group-level significance and suggests limited applicability of targeting this pathway for all patients.

Conclusions:

• The developed statistical model accurately identifies patient-specific pathway dysregulation.
• The methodology provides insights into disease heterogeneity and aids in personalized treatment decisions.
• The model is flexible, extendable to complex study designs, and implementable in standard statistical packages.